Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma Industry Stares Down Biggest Patent Cliff in Decades
Most companies sell a hit product for as long as customers want it. For drugmakers, a clock starts before a drug is even approved: Patents run out, lower-priced copycats flood in and sales collapse. Billions of dollars of annual sales can…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 43 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, August 28, 2026 –…
Cipla Pharma license cancellation order withdrawn as HC chides Maharashtra FDA
The Maharashtra FDA on Saturday withdrew its order to cancel the drug sale licence of Cipla Pharma & Life Sciences Ltd's Carry and Forwarding unit in Pune after the Bombay High Court pulled up the regulator for going 'overboard' and behaving in a…
Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Govt
Argentina has committed to reduce barriers to facilitate entry of Indian pharmaceutical sector in the South American nation, the commerce ministry said on Saturday. This is expected to provide greater opportunities for Indian pharmaceutical…
Maharashtra FDA crackdown on Cipla Pharma's Pune unit, cancels licence over 'unauthorised promotional text' on Reactin Plus
The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licences of Cipla Pharma & Life Sciences Ltd's Carry and Forwarding (C&F) facility at Wadki in Pune, citing serious irregularities found during inspections linked to…
Deutsche Bank AG Takes $1.90 Million Position in Urogen Pharma $URGN
Deutsche Bank AG acquired a new position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 51,550 shares of the…
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Average Rating of 'Moderate Buy' from Analysts
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) has earned a consensus recommendation of 'Moderate Buy' from the twenty-three brokerages that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a…
-169839963500416_9.webp)
Going Overboard': Maharashtra FDA Withdraws Order Cancelling Cipla Licence After HC Rap
Mumbai: The Maharashtra Food and Drug Administration (FDA) on Saturday withdrew its order cancelling the drug sale licences of Cipla Pharma & Life Sciences Ltd's carrying and forwarding (C&F) facility in Pune, after the Bombay High Court criticised…
Walmart settles US government's opioid lawsuit
Walmart has settled a United States government lawsuit accusing the largest US retailer of fueling a nationwide opioid epidemic by unlawfully dispensing prescriptions from its pharmacies. The US Department of Justice and Walmart confirmed the…
NY Times: Lindsay Clancy Sure Has a Lot of Female Supporters
It seems obvious and undeniable to me and a lot of other people that Lindsay Clancy is guilty in the colloquial sense of the word. She murdered her three children and the trial is really just about whether she can claim some kind of diminished…
Nifty, Sensex post notable weekly losses over caution on global interest rates
Indian equity benchmarks posted notable losses for the third consecutive week amid concerns over global interest rates and geopolitical uncertainty. Nifty declined 0.31 per cent during the week and added 0.35 per cent on the last trading day to…
Maharashtra FDA cancels Cipla Pune unit's sale licence; company contests order
Drugmaker Cipla said it was contesting the Maharashtra Food and Drug Administration's order involving irregularities involving storage, packaging and recall procedures at its Pune unit. “Cipla Pharma & Life Sciences (CPLS) has contested the…
Growth Stocks To Keep An Eye On - August 28th
Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Teledyne Technologies, Ascendis Pharma A/S, Jersey Mike's, Digital Turbine, Hamilton Lane, and Hercules Capital are the seven Growth stocks to watch today, according to…
Federal Rescheduling Sets The Stage For Marijuana Business Acquisitions As Pharma And Ag Firms Eye Industry (Op-Ed)
“The practical question isn't whether this is something to celebrate, it's whether your business is positioned to be a consolidator, an attractive acquisition target or something different.” By Christopher B. Lynch, Dickinson Wright…
ArcLight's new transmission company, EQT bets on rugby, Trian passes on Wendy's
🚑 360training, a portfolio company of GreyLion and Vestar Capital Partners, acquired select assets of eMedCert, including its life support certification training. Go deeper • AirPro Diagnostics, a Rotunda Capital Partners portfolio…
Receive a Daily briefing on Pharma Industry News
Get Started